About Wake Forest University, Health Sciences Section on Hematology and Oncology
Clinical Trials at Wake Forest University, Health Sciences Section on Hematology and Oncology
During the past decade, Wake Forest University, Health Sciences Section on Hematology and Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Wake Forest University, Health Sciences Section on Hematology and Oncology
According to Clinical.Site data, the most researched conditions in "Wake Forest University, Health Sciences Section on Hematology and Oncology" are
"Acute Myeloid Leukemia (AML)" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Wake Forest University, Health Sciences Section on Hematology and Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Wake Forest University, Health Sciences Section on Hematology and Oncology
Most popular intervention types in "Wake Forest University, Health Sciences Section on Hematology and Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (1 trials), "Carfilzomib" (1 trials), "Dexamethasone" (1 trials), "Elacytarabine" (1 trials) and "Investigator's Choice" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Wake Forest University, Health Sciences Section on Hematology and Oncology
The vast majority of trials in "Wake Forest University, Health Sciences Section on Hematology and Oncology" are
2 trials for "All" genders.
Clinical Trials Status at Wake Forest University, Health Sciences Section on Hematology and Oncology
Currently, there are NaN active trials in "Wake Forest University, Health Sciences Section on Hematology and Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Wake Forest University, Health Sciences Section on Hematology and Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Wake Forest University, Health Sciences Section on Hematology and Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".